157 related articles for article (PubMed ID: 12167341)
1. Interleukin 17 modulates the immune response to vaccinia virus infection.
Patera AC; Pesnicak L; Bertin J; Cohen JI
Virology; 2002 Jul; 299(1):56-63. PubMed ID: 12167341
[TBL] [Abstract][Full Text] [Related]
2. IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system.
Gherardi MM; RamÃrez JC; Esteban M
J Gen Virol; 2003 Aug; 84(Pt 8):1961-1972. PubMed ID: 12867626
[TBL] [Abstract][Full Text] [Related]
3. Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2.
Karupiah G; Coupar BE; Andrew ME; Boyle DB; Phillips SM; Müllbacher A; Blanden RV; Ramshaw IA
J Immunol; 1990 Jan; 144(1):290-8. PubMed ID: 2295796
[TBL] [Abstract][Full Text] [Related]
4. Effects of virally expressed interleukin-10 on vaccinia virus infection in mice.
Kurilla MG; Swaminathan S; Welsh RM; Kieff E; Brutkiewicz RR
J Virol; 1993 Dec; 67(12):7623-8. PubMed ID: 8230481
[TBL] [Abstract][Full Text] [Related]
5. Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice.
Karupiah G; Woodhams CE; Blanden RV; Ramshaw IA
J Immunol; 1991 Dec; 147(12):4327-32. PubMed ID: 1684375
[TBL] [Abstract][Full Text] [Related]
6. IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17.
Kohyama S; Ohno S; Isoda A; Moriya O; Belladonna ML; Hayashi H; Iwakura Y; Yoshimoto T; Akatsuka T; Matsui M
J Immunol; 2007 Sep; 179(6):3917-25. PubMed ID: 17785829
[TBL] [Abstract][Full Text] [Related]
7. Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity.
Reading PC; Smith GL
J Virol; 2003 Sep; 77(18):9960-8. PubMed ID: 12941906
[TBL] [Abstract][Full Text] [Related]
8. Mucosal and systemic immune responses to measles virus haemagglutinin in mice immunized with a recombinant vaccinia virus.
Etchart N; Wild F; Kaiserlian D
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2471-8. PubMed ID: 8887480
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-15 mediates potent antiviral responses via an interferon-dependent mechanism.
Foong YY; Jans DA; Rolph MS; Gahan ME; Mahalingam S
Virology; 2009 Oct; 393(2):228-37. PubMed ID: 19729181
[TBL] [Abstract][Full Text] [Related]
10. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
Harrington LE; Most Rv Rv; Whitton JL; Ahmed R
J Virol; 2002 Apr; 76(7):3329-37. PubMed ID: 11884558
[TBL] [Abstract][Full Text] [Related]
11. Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells.
Selin LK; Santolucito PA; Pinto AK; Szomolanyi-Tsuda E; Welsh RM
J Immunol; 2001 Jun; 166(11):6784-94. PubMed ID: 11359837
[TBL] [Abstract][Full Text] [Related]
12. T-bet is required for protection against vaccinia virus infection.
Matsui M; Moriya O; Yoshimoto T; Akatsuka T
J Virol; 2005 Oct; 79(20):12798-806. PubMed ID: 16188982
[TBL] [Abstract][Full Text] [Related]
13. The role for host-immune factors in the in vivo antiviral effects of tumour necrosis factor.
Lidbury BA; Ramshaw IA; Sambhi SK
Cytokine; 1995 Feb; 7(2):157-64. PubMed ID: 7780035
[TBL] [Abstract][Full Text] [Related]
14. Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes.
Legrand FA; Verardi PH; Jones LA; Chan KS; Peng Y; Yilma TD
J Virol; 2004 Mar; 78(6):2770-9. PubMed ID: 14990697
[TBL] [Abstract][Full Text] [Related]
15. Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression.
Brutkiewicz RR; Klaus SJ; Welsh RM
Nat Immun; 1992; 11(4):203-14. PubMed ID: 1421956
[TBL] [Abstract][Full Text] [Related]
16. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection.
Tanaka-Kataoka M; Kunikata T; Takayama S; Iwaki K; Ohashi K; Ikeda M; Kurimoto M
Cytokine; 1999 Aug; 11(8):593-9. PubMed ID: 10433806
[TBL] [Abstract][Full Text] [Related]
17. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.
Coupar BE; Andrew ME; Both GW; Boyle DB
Eur J Immunol; 1986 Dec; 16(12):1479-87. PubMed ID: 3493144
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus E3 14.7-kilodalton protein, an antagonist of tumor necrosis factor cytolysis, increases the virulence of vaccinia virus in severe combined immunodeficient mice.
Tufariello JM; Cho S; Horwitz MS
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10987-91. PubMed ID: 7971996
[TBL] [Abstract][Full Text] [Related]
19. The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model.
Symons JA; Adams E; Tscharke DC; Reading PC; Waldmann H; Smith GL
J Gen Virol; 2002 Nov; 83(Pt 11):2833-2844. PubMed ID: 12388820
[TBL] [Abstract][Full Text] [Related]
20. In vivo delivery of interleukin-6 using vaccinia virus: effects on T lymphocytes in nude mice.
Nakagawa N; Nakagawa T; Acres B; Yasukawa K; Kieny MP
Eur Cytokine Netw; 1991; 2(1):11-6. PubMed ID: 1873489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
